Therefore, the newly discovered triple effect of selective ROCK2 inhibition to target convergently pro-inflammatory, fibrotic, and metabolic pathways in vivo underscores the integral role of ROCK2 signaling in regulation of liver fibrosis. The gene discussed is ROCK2; the disease is Hepatic fibrosis.